Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Trial of Partial Breast Proton Therapy for Early Stage Breast Cancer With Low and Intermediate Risk Factors.

NCT01310530 is registered in ClinicalTrials.gov with Loma Linda University as lead sponsor.

NCT NCT01310530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01310530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Trial of Partial Breast Proton Therapy for Early Stage Breast Cancer With Low and Intermediate Risk Factors.
Lead sponsor
Loma Linda University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 4, 2011
Completion date
December 31, 2026
Enrollment
150 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer